Stock Events

Reviva Pharmaceuticals 

$0.84
2
+$0+0.2% Friday 21:00

Statistics

Day High
0.84
Day Low
-
52W High
3
52W Low
0.71
Volume
0
Avg. Volume
12,590
Mkt Cap
106.09M
P/E Ratio
0
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28MarExpected
Q2 2022
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Next
-0.55
-0.43
-0.3
-0.18
Expected EPS
-0.28
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RVPHW. It's not an investment recommendation.

About

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attention–deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.
Show more...
CEO
Employees
10
Country
US
ISIN
US76152G1186

Listings